Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Body

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Bone|December 26, 2006
PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumorGert G Van den Eynden, Aymeric Neyret, Glawdys Fumey, et al.
The Prostate|August 19, 2014
Patient preferences for treatments to delay bone metastasesA Brett Hauber, Jorge Arellano, Yi Qian, et al.
International Journal of Clinical Practice|March 27, 2019
Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohortFelicia Baleanu, Pierre Bergmann, Anne Sophie Hambye, et al.
Calcified Tissue International|July 20, 2022
Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 CasesAriadne Bosman, Andrea Palermo, Julien Vanderhulst, et al.
Bone|September 7, 2011
Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblastsHichame Id Boufker, Laurence Lagneaux, Hussein Fayyad-Kazan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 19, 2014
Patients' preferences for bone metastases treatments in France, Germany and the United KingdomGuy Hechmati, A Brett Hauber, Jorge Arellano, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2020
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOFJessica Pepe, Jean-Jacques Body, Peyman Hadji, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2024
Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA studySławomir Jeka, Eva Dokoupilová, Alan Kivitz, et al.
Journal of Bone Oncology|March 27, 2018
Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective studyRoger von Moos, Jean-Jacques Body, Oliver Guenther, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone diseaseIngo J Diel, Jean-Jacques Body, Alison T Stopeck, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Bone|December 26, 2006
PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumorGert G Van den Eynden, Aymeric Neyret, Glawdys Fumey, et al.
The Prostate|August 19, 2014
Patient preferences for treatments to delay bone metastasesA Brett Hauber, Jorge Arellano, Yi Qian, et al.
International Journal of Clinical Practice|March 27, 2019
Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohortFelicia Baleanu, Pierre Bergmann, Anne Sophie Hambye, et al.
Calcified Tissue International|July 20, 2022
Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 CasesAriadne Bosman, Andrea Palermo, Julien Vanderhulst, et al.
Bone|September 7, 2011
Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblastsHichame Id Boufker, Laurence Lagneaux, Hussein Fayyad-Kazan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 19, 2014
Patients' preferences for bone metastases treatments in France, Germany and the United KingdomGuy Hechmati, A Brett Hauber, Jorge Arellano, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2020
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOFJessica Pepe, Jean-Jacques Body, Peyman Hadji, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2024
Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA studySławomir Jeka, Eva Dokoupilová, Alan Kivitz, et al.
Journal of Bone Oncology|March 27, 2018
Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective studyRoger von Moos, Jean-Jacques Body, Oliver Guenther, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone diseaseIngo J Diel, Jean-Jacques Body, Alison T Stopeck, et al.
Pageof 14